Related Experiment Videos
Primary splenic diffuse large B-cell lymphoma manifesting in red pulp
Makoto Kashimura1, Masahiro Noro, Bunshiro Akikusa
1Department of Hematology, Matsudo City Hospital, 4005 Kamihongo Matsudo, Chiba, 271-8511, Japan. kasimura@mvi.biglobe.ne.jp
Virchows Archiv : an International Journal of Pathology
|September 27, 2008
Summary
This study identifies a unique form of diffuse large B-cell lymphoma (DLBCL) originating in the spleen's red pulp. These aggressive lymphomas show distinct patterns, differing from typical nodal DLBCL.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Diffuse large B-cell lymphoma (DLBCL) is a common non-Hodgkin lymphoma.
- Splenic involvement in DLBCL can occur, but primary red pulp involvement is less understood.
- Understanding distinct DLBCL subtypes is crucial for accurate diagnosis and treatment.
Purpose of the Study:
- To characterize the clinicopathological features of DLBCL involving the splenic red pulp.
- To determine if primary splenic red pulp DLBCL represents a distinct clinicopathological entity.
Main Methods:
- Retrospective analysis of six cases of DLBCL with red pulp splenic involvement.
- Clinical data review, including symptoms, disease course, and organ involvement.
- Pathological examination of tissue samples, including immunohistochemistry (CD5 expression).
Main Results:
- All six patients presented with B symptoms and aggressive disease.
- Lymphoma cells infiltrated the splenic red pulp diffusely.
- Bone marrow and liver involvement were common; lymph node involvement was rare at presentation.
- Peripheral blood involvement and CD5 expression were observed in a subset of patients.
Conclusions:
- Primary splenic DLBCL manifesting in the red pulp exhibits unique clinical and pathological features.
- These findings suggest it may represent a distinct clinicopathological entity.
- Further research is warranted to confirm its distinctness and guide therapeutic strategies.
Related Concept Videos
Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...